SCHEMBL14648014

SCHEMBL14648014

O=C(c1nccs1)N1CCN(C2CN(C(=O)c3cccc4oc(-c5cccc(Cl)c5)nc34)C2)CC1

nearest known ligand 0.60

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 17/20 0.60
FAAH O00519 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
GRM5 P41594 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14647950 0.92 MGLL (0.60) MGLLFAAH
SCHEMBL911383 0.91 MGLL (0.70) MGLLFAAH
SCHEMBL912501 0.88 MGLL (0.59) MGLLFAAH
SCHEMBL14648007 0.87 MGLL (0.60) MGLLFAAH
SCHEMBL14648031 0.86 MGLL (0.55) MGLLFAAH
SCHEMBL14647908 0.83 MGLL (0.55) MGLLFAAH
SCHEMBL912001 0.81 MGLL (0.67) MGLLFAAH
SCHEMBL912614 0.78 MGLL (0.70) MGLLFAAH
SCHEMBL911853 0.76 MGLL (0.58) MGLLFAAHCYP3A4CYP2C9GRM5
SCHEMBL912419 0.76 MGLL (1.00) MGLLFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421823-B1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2015-01-14 EP disclosed
EP-2421825-B9 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-08-20 EP disclosed
EP-2421825-B1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-01-01 EP disclosed
US-8362000-B2 Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA NV (BE) 2013-01-29 US disclosed